Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adcetris
Pharma
ASH: Adcetris, Opdivo boost hopes for another ADC, PD-1 combo
Seagen trotted out new data suggesting its ADC Adcetris could work with BMS' PD-1 drug Opdivo in two classical Hodgkin lymphoma settings.
Angus Liu
Dec 10, 2023 7:30pm
Seagen CEO on his next stop, the Pfizer deal and ADCs
Jun 8, 2023 11:36am
ASCO: Seagen's top-selling drug under threat from Opdivo
Jun 4, 2023 8:00am
Pfizer snaps up ADC cancer specialist Seagen for $43B
Mar 13, 2023 10:51am
Seagen's revenue up 25% in 2022 as growth drivers 'firing'
Feb 16, 2023 10:42am
Seagen taps former Novartis oncology chief Epstein as CEO
Nov 10, 2022 9:57am
